ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
970
Employees970
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
970
Employees970

ANIP Key Statistics

Market cap
1.76B
Market cap1.76B
Price-Earnings ratio
16.21
Price-Earnings ratio16.21
Dividend yield
Dividend yield
Average volume
473.92K
Average volume473.92K
High today
$76.71
High today$76.71
Low today
$73.39
Low today$73.39
Open price
$74.47
Open price$74.47
Volume
230.25K
Volume230.25K
52 Week high
$99.50
52 Week high$99.50
52 Week low
$70.15
52 Week low$70.15

Stock Snapshot

The current ANI Pharmaceuticals(ANIP) stock price is $76.54, with a market capitalization of 1.76B. The stock trades at a price-to-earnings (P/E) ratio of 16.21.

On 2026-08-14, ANI Pharmaceuticals(ANIP) stock moved within a range of $73.39 to $76.71. With shares now at $76.54, the stock is trading +4.3% above its intraday low and -0.2% below the session's peak.

Trading activity shows a volume of 230.25K, compared to an average daily volume of 473.92K.

The stock's 52-week range extends from a low of $70.15 to a high of $99.50.

The stock's 52-week range extends from a low of $70.15 to a high of $99.50.

ANIP News

Simply Wall St 18h
ANI Pharmaceuticals Could Be 34% Undervalued As Earnings And Guidance Hold

Advertisement ANI Pharmaceuticals stock reacts to earnings and guidance update ANI Pharmaceuticals (ANIP) is in focus after releasing second quarter and first...

ANI Pharmaceuticals Could Be 34% Undervalued As Earnings And Guidance Hold
Simply Wall St 6d
ANI Pharmaceuticals Stock Slides As Cortrophin Concentration Clouds Profit Quality

ANI Pharmaceuticals just took a 5.3% hit in a single session, yet the earnings story looks more like growing pains than a broken thesis. You have a stock that c...

ANI Pharmaceuticals Stock Slides As Cortrophin Concentration Clouds Profit Quality

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.